Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 14.42
+0.32 (2.27%)
Aug 21, 2026, 5:38 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €721.35 million as of August 21, 2026. Its market cap has increased by 288.58% in one year.
Market Cap
721.35M
Enterprise Value
770.94M
Revenue
70.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€14.42
ChartMarket Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 721.35M, an increase of 393.85%. That is a compound annual growth rate of 8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 721.35M | 175.14% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.93B |
| Inventiva | 949.85M |
| MedinCell | 893.48M |
| DBV Technologies | 739.20M |
| Valneva SE | 562.49M |
| Valerio Therapeutics Société anonyme | 424.53M |
| Transgene | 221.30M |
| Cellectis | 208.64M |